Original Research
Accepted on 31 Oct 2024
Nrf2/HO-1 and BDNF/VEGF signaling in stress-intensified PTZinduced epilepsy in mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446304
Type at least 3 characters
2,239 articles
Articles
Original Research
Accepted on 31 Oct 2024
Molecular targets and mechanisms of Sijunzi Decoction in the treatment of Parkinson's disease: evidence from network pharmacology, molecular docking, molecular dynamics simulation, and experimental validation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1487474
Original Research
Accepted on 31 Oct 2024
Cannabidiol inhibits Transient Receptor Potential Canonical 4 and modulates excitability of pyramidal neurons in mPFC
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1431758
Original Research
Accepted on 31 Oct 2024
Effect of NLRP3 inflammasome induced astrocyte phenotype alteration in morphine tolerance
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1434295
Editorial
Published on 31 Oct 2024
Editorial: Current progress and challenges in psychopharmacology research
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1504943
Original Research
Published on 30 Oct 2024
Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1466953
- 295 views
Brief Research Report
Published on 30 Oct 2024
Increased functional connectivity between brain regions involved in social cognition, emotion and affective-value in psychedelic states induced by N,N-Dimethyltryptamine (DMT)
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1454628
- 330 views
Original Research
Accepted on 28 Oct 2024
Correlation of the DRD2 Gene Polymorphism with Psychopathology and Predictive Antimanic Responses in Patients with Bipolar Mania
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1465356
Original Research
Published on 28 Oct 2024
Patients with dementia: prevalence and type of drug–drug interactions
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472932
- 111 views
Mini Review
Published on 28 Oct 2024
The impacts of tobacco and nicotine on HIV-1 infection, inflammation, and the blood-brain barrier in the central nervous system
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477845
- 160 views
Review
Accepted on 25 Oct 2024
Progress in GABAA receptor agonists for insomnia disorder
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1432726
Original Research
Accepted on 25 Oct 2024
Overexpression of endothelial S1pr2 promotes blood-brain barrier disruption via JNK/c-Jun/MMP-9 pathway after traumatic brain injury in both in vivo and in vitro models
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1448570
Original Research
Published on 25 Oct 2024
Dopamine internalization via Uptake2 and stimulation of intracellular D5-receptor-dependent calcium mobilization and CDP-diacylglycerol signaling
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1422998
- 162 views
Original Research
Accepted on 23 Oct 2024
Adverse Event Profile of Lorazepam: A Real-World Pharmacovigilance Study Using the FDA Adverse Event Reporting System Database
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1465245
Systematic Review
Accepted on 23 Oct 2024
Knowledge Domain and Trends in Treatment-resistant Schizophrenia Research: A Bibliometrics Analysis and Systematic Review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1478625
Systematic Review
Published on 23 Oct 2024
Stem cell-derived exosomes for ischemic stroke: a conventional and network meta-analysis based on animal models
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1481617
- 128 views